basic sceince research


Prostate Center of Excellence

The Center for Prostate Disease Research (CPDR) is a DoD research and clinical care center established by the U.S. Congress in 1992 to care for military service members and their families diagnosed with prostate cancer and prostate related disease. In 2010, CPDR received the prestigious distinction of being designated a DoD Prostate Center of Excellence. More recently, CPDR became a member of the Cancer Center of Excellence at Walter Reed-Bethesda (only DoD medical center to receive this distinction). In the past 20 years, the CPDR has grown into a robust program that is internationally recognized as a premier prostate patient care and research center.



The CPDR Clinical Research Program mission is to provide state-of-the-art treatment and clinical research opportunities for military health care beneficiaries with prostate cancer and other prostate diseases.

Services Provided or Supported at our Clinical Center:

  • Multi-disciplinary Prostate Cancer Clinic for Newly Diagnosed Patients
  • Recurrent Prostate Cancer Clinic
  • Clinical Trial Services
  • Preoperative Counseling Class for Surgery Patients
  • Psychological Support
  • Nutrition Classes
  • Male Sexuality Issues
  • Monthly Support Groups
  • Numerous Patient Education Forums (Guest Speakers, Newsletters, and etc.)

State-of-the-art prostate cancer treatments:

  • Robotic-assisted laparoscopic prostatectomy
  • Intensity modulated Radiation Therapy w/ Image guided radiation therapy
  • Brachytherapy


Eligibility for Care

All Active Duty, Retirees, and their family members regardless of age.


2018 AACR Annual Meeting
Chicago, Illinois April 14-18, 2018

The 2018 AACR Annual Meeting gathered this year at McCormick Place, Chicago, Illinois from April 14 to 18 under the theme of Driving Innovative Cancer Science to Patient Care. The Center for Prostate Disease Research (CPDR) multi-disciplinary team - together with collaborators – delivered one podium presentation and 12 poster presentations. The team was co-led by Dr. Shiv Srivastava, CPDR Co-Director and Professor, and Dr. Albert Dobi, Associate Director, CPDR and Research Assistant Professor, of the Department of Surgery, USU and WRNMMC.

Read Full Article

Read the March 2019 CPDR E-Newsletter

Go to the WRNMMC UsToo! Newsletter Archive or CPDR E-Newsletter Archive


ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development
Scientific Reports | 7: 1109 | DOI:10.1038/s41598-017-01187-4

Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
Mol Cancer Res. 2017 Oct;15(10):1308-1317. doi: 10.1158/1541-7786.MCR-17-0058. Epub 2017 Jun 12.

Ethnicity and ERG Frequency in Prostate Cancer
Nat Rev Urol. 2017 Sep 5. doi: 10.1038/nrurol.2017.140. [Epub ahead of print]